Guest guest Posted April 17, 2010 Report Share Posted April 17, 2010 HCV ADVOCATE WEEKLY NEWS REVIEW Week Ending: April 17, 2010 This Issue: HCV Advocate EASL 2010 Coverage First Trial in Southern Nevada Hepatitis Case Set to Begin Hepatitis Timebomb Ticking in Tayside Clinical Trial: Rituximab (anti-CD20) for the Treatment of Hepatitis C Associated Cryoglobulinemic Vasculitis (HCV-CV) Doctor Guilty of Forgery Hepatitis C Cases Elevate the Fear of HIV Infection Upsurge Biotech and Pharma Focus on Hepatitis C Market Report -- In Play (IDIX) Campaigner Wins Tainted Blood Case Jury Seated in Las Vegas Hepatitis Exposure Trial http://www.hcvadvocate.org/news/newsRev/2010/NewsRev-357.html Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.